Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a review of clinical data

Furqan, F; Hamadani, M

Hamadani, M (通讯作者)，Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022; 13 ():

Abstract

Loncastuximab tesirine-lpyl (ADC Therapeutics) is an anti-CD19 antibody-drug conjugate which consists of anti-CD19 antibody and cytotoxic alkylating a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索